Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9® lead to promotion versus suppression of prostate cancer metastasis
- Tzu Hua Lin
- , Soo Ok Lee
- , Yuanjie Niu
- , Defeng Xu
- , Liang Liang
- , Lei Li
- , Shauh Der Yeh
- , Naohiro Fujimoto
- , Shuyuan Yeh
- , Chawnshang Chang
研究成果: 雜誌貢獻 › 文章 › 同行評審
108
!!Link opens in a new tab
引文
斯高帕斯（Scopus）